2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

2024 ASCO® Annual Meeting Insights Hub
S

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Sapna Patel
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Sapna Patel
631 views
July 11, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn
Skin
05:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker Analysis & Updated Clinical…

Feat. L. Burton
35:23
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

Feat. S. Patel
24:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and A…

Feat. Z. Eroglu
11:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, …

Feat. D. Johnson
25:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Insights in Melanoma"

Feat. O. Hamid
14:46
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Safety & Efficacy of First-in-Class C…

Feat. S. Patel
11:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We B…

Feat. P. Corrie
02:57
ecancer

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi vs.…

Feat. C. Blank
15:18
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Me…

Feat. A. Betof Warner
03:12
ecancer

ASCO® 2024 Insights: "PIVOTAL Study - Neoadjuvant Daromun vs. I…

Feat. A. Hauschild
09:13
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "QoL Data With Neoadjuvant Ipi & Nivo …

Feat. J. Lijnsvelt
03:36
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PIVOTAL Study - Daromun vs. Immediate Sur…

Feat. A. Hauschild
09:54
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Ou…

Feat. H. Tawbi
08:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in …

Feat. C. Blank
06:48
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "SCOPE Trial - Efficacy & Safety of SC…

Feat. H. Shaw
14:01
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Macroscopic Stage III Melanoma and Immuno…

Feat. H. Kluger
20:16
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in S…

Feat. H. Tawbi
11:33
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "PD-1-Refractory Advanced Melanoma - Gettin…

Feat. M. Mckean
09:25
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NEO-TIM Trial - Combination or Sequence o…

Feat. P. Ascierto
09:31
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Roginolisib, an Oral, Highly Selective an…

Feat. A. Di Giacomo
12:22
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KEYNOTE-942 Trial - 3-Year Update on mRNA…

Feat. J. Weber
11:34
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RELATIVITY-048 Trial - Efficacy and Safet…

Feat. P. Ascierto
10:17
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RegoMel Trial - Regorafenib in Patients W…

Feat. I. Dirven
08:10
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "OBX-115, IL2-Sparing Engineered TIL Cell …

Feat. R. Amaria
03:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib …

Feat. A. Hauschild
01:52
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Individualized Neoantigen Therapy mRNA-41…

Feat. M. Mckean
07:38
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Novel RNA-Nanoparticle Vaccine for the Tr…

Feat. B. Doonan